J&J | JNJ - Current Liabilities



J&J reported $56.9B in Current Liabilities for its fiscal quarter ending in March of 2025.


Current Liabilities Change Date
AbbVie USD 36.4B 2.35B Mar/2025
Abbott USD 13.44B 435M Jun/2025
Amgen USD 20.48B 2.53B Jun/2025
AstraZeneca USD 33.54B 4.41B Jun/2025
Baxter International USD 3.48B 3.03B Mar/2025
Bayer EUR 29.78B 1.82B Jun/2025
Becton, Dickinson and Co. USD 8.16B 469M Jun/2025
Biogen USD 3.18B 2.11B Jun/2025
Boston Scientific USD 5.06B 1.34B Mar/2025
Bristol-Myers Squibb USD 27.53B 3.46B Jun/2025
CONMED USD 294.84M 11.69M Jun/2025
Cooper Companies USD 1.01B 2.4M Jul/2025
Dexcom USD 3.31B 271.6M Jun/2025
Edwards Lifesciences USD 1.39B 110.4M Mar/2025
Eli Lilly USD 39.02B 8.95B Jun/2025
Gilead Sciences USD 11.19B 1.15B Jun/2025
GlaxoSmithKline GBP 20.38B 453M Jun/2025
Globus Medical USD 424.66M 39.96M Jun/2025
Hologic USD 962.5M 27.2M Jun/2025
Insulet USD 1.01B 489.7M Jun/2025
Integra LifeSciences USD 929.81M 11.35M Jun/2025
Intuitive Surgical USD 2.21B 197.4M Jun/2025
J&J USD 56.9B 6.58B Mar/2025
Medtronic USD 12.88B 1.04B Apr/2025
Merck USD 26.04B 863M Jun/2025
Merit Medical Systems USD 225.57M 28.75M Jun/2025
Novartis USD 31.71B 95M Jun/2025
Pfizer USD 37.73B 1.27B Jun/2025
Regeneron Pharmaceuticals USD 3.67B 100.4M Jun/2025
Roche Holding CHF 27.02B 424M Dec/2024
Sanofi 29.06B 3.16B Jun/2025
Stryker USD 7.29B 641M Jun/2025
Tandem Diabetes Care USD 251.69M 36.48M Jun/2025
Teva Pharmaceutical Industries USD 11.86B 704M Jun/2025
Vertex Pharmaceuticals USD 4.14B 355.2M Jun/2025
Zimmer Biomet Holdings USD 2.7B 404.6M Jun/2025
Zoetis USD 3.37B 19M Jun/2025